Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The M4 muscarinic acetylcholine receptor (M4 mAChR), encoded by the CHRM4 gene, is a Gi/o-coupled GPCR that acts as an inhibitory autoreceptor for acetylcholine, particularly in the striatum. It regulates dopaminergic neurotransmission and plays a role in extrapyramidal motor control. M4 mAChR is implicated in various neurological disorders and represents a therapeutic target for Alzheimer's disease, schizophrenia, Parkinson's disease, and other conditions such as myelodysplastic syndrome and anemia.
Gi/o-mediated inhibition of adenylate cyclase; modulation of potassium channels and phosphoinositide breakdown.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on M4 Muscarinic Acetylcholine Receptor (None specified).